Integrated Investment Consultants’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.31M | Sell |
27,551
-1,265
| -4% | -$146K | 0.7% | 29 |
|
|
2025
Q4 | $3.03M | Buy |
28,816
+10,087
| +54% | +$947K | 0.59% | 35 |
|
|
2025
Q3 | $1.57M | Sell |
18,729
-791
| -4% | -$65.2K | 0.27% | 58 |
|
|
2025
Q2 | $1.55M | Sell |
19,520
-363
| -2% | -$28.9K | 0.3% | 56 |
|
|
2025
Q1 | $1.78M | Sell |
19,883
-8,667
| -30% | -$809K | 0.36% | 49 |
|
|
2024
Q4 | $2.84M | Sell |
28,550
-584,862
| -95% | -$60.3M | 0.59% | 35 |
|
|
2024
Q3 | $2.34M | Buy |
613,412
+597,596
| +3,778% | +$71M | 0.51% | 32 |
|
|
2024
Q2 | $2.09M | Hold |
15,816
| – | – | 0.57% | 32 |
|
|
2024
Q1 | $2.09M | Buy |
15,816
+1
| +0% | +$123 | 0.57% | 32 |
|
|
2023
Q4 | $1.72M | Buy |
15,815
+20
| +0.1% | +$2.08K | 0.55% | 35 |
|
|
2023
Q3 | $1.63M | Sell |
15,795
-2,000
| -11% | -$216K | 0.59% | 30 |
|
|
2023
Q2 | $2.05M | Buy |
17,795
+136
| +0.8% | +$15.4K | 0.65% | 26 |
|
|
2023
Q1 | $1.88M | Sell |
17,659
-1,362
| -7% | -$147K | 0.59% | 29 |
|
|
2022
Q4 | $2.11M | Buy |
19,021
+359
| +2% | +$36.7K | 0.71% | 26 |
|
|
2022
Q3 | $1.61M | Sell |
18,662
-452
| -2% | -$40.4K | 0.64% | 27 |
|
|
2022
Q2 | $1.74M | Buy |
19,114
+788
| +4% | +$69.9K | 0.63% | 26 |
|
|
2022
Q1 | $1.5M | Sell |
18,326
-725
| -4% | -$57.2K | 0.41% | 35 |
|
|
2021
Q4 | $1.46M | Sell |
19,051
-151
| -0.8% | -$12K | 0.39% | 37 |
|
|
2021
Q3 | $1.44M | Sell |
19,202
-244
| -1% | -$18.6K | 0.42% | 34 |
|
|
2021
Q2 | $1.51M | Buy |
19,446
+1,181
| +6% | +$87.8K | 0.44% | 37 |
|
|
2021
Q1 | $1.34M | Sell |
18,265
-2,131
| -10% | -$157K | 0.46% | 32 |
|
|
2020
Q4 | $1.59M | Buy |
20,396
+1,115
| +6% | +$85.3K | 0.6% | 33 |
|
|
2020
Q3 | $1.53M | Hold |
19,281
| – | – | 0.71% | 24 |
|
|
2020
Q2 | $1.42M | Buy |
19,281
+38
| +0.2% | +$2.86K | 0.67% | 25 |
|
|
2020
Q1 | $1.41M | Sell |
19,243
-1,584
| -8% | -$124K | 0.84% | 26 |
|
|
2019
Q4 | $1.81M | Sell |
20,827
-4,377
| -17% | -$360K | 0.75% | 27 |
|
|
2019
Q3 | $2.02M | Sell |
25,204
-1,572
| -6% | -$126K | 1.04% | 18 |
|
|
2019
Q2 | $2.14M | Sell |
26,776
-4,088
| -13% | -$313K | 1.1% | 15 |
|
|
2019
Q1 | $2.45M | Sell |
30,864
-2,473
| -7% | -$185K | 1.31% | 14 |
|
|
2018
Q4 | $2.43M | Sell |
33,337
-73
| -0.2% | -$5.15K | 1.3% | 11 |
|
|
2018
Q3 | $2.26M | Hold |
33,410
| – | – | 1.1% | 11 |
|
|
2018
Q2 | $1.94M | Sell |
33,410
-151
| -0.4% | -$8.52K | 1.01% | 13 |
|
|
2018
Q1 | $1.74M | Buy |
+33,561
| New | +$1.81M | 0.69% | 18 |
|
|
2017
Q3 | $2.03M | Buy |
33,179
+53
| +0.2% | +$3.21K | 0.88% | 15 |
|
|
2017
Q2 | $2.03M | Hold |
33,126
| – | – | 0.91% | 13 |
|
|
2017
Q1 | $2.01M | Hold |
33,126
| – | – | 0.92% | 13 |
|
|
2016
Q4 | $1.86M | Hold |
33,126
| – | – | 0.89% | 14 |
|
|
2016
Q3 | $1.98M | Hold |
33,126
| – | – | 1.01% | 12 |
|
|
2016
Q2 | $1.82M | Buy |
33,126
+233
| +0.7% | +$12.4K | 1.03% | 13 |
|
|
2016
Q1 | $1.74M | Buy |
32,893
+64
| +0.2% | +$3.13K | 1% | 14 |
|
|
2015
Q4 | $1.61M | Buy |
+32,829
| New | +$1.66M | 1.27% | 13 |
|
Other funds holding MRK
VCM
VPM
Integrated Investment Consultants's MRK Position: Q1 2026 in Review
Integrated Investment Consultants reduced its Merck (MRK) stake by 4.4% in Q1 2026, selling an estimated $146K and leaving 27,551 shares worth $3.31M. The position accounts for 0.7% of the portfolio, ranked #29.
Integrated Investment Consultants first reported a position in MRK in Q4 2015 and has held it in 41 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Integrated Investment Consultants held 27,551 shares of Merck worth $3.31M as of Q1 2026.
- Integrated Investment Consultants sold 1,265 Merck shares in Q1 2026, an estimated $146K.
- Merck made up 0.7% of Integrated Investment Consultants's portfolio in Q1 2026, its #29 holding.
- Integrated Investment Consultants first reported a position in Merck in Q4 2015 and has held it in 41 quarters since.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Integrated Investment Consultants's 13F filing for Q1 2026, filed 1 Jun 2026.